DuPont Launches AmberChrom™ SIL Silica Gel for Chromatography to Advance Manufacturing of GLP-1 and Other Peptide Therapeutics
PR Newswire•22/10/2026•09:00 ET
1
Key Highlights
- ➤DuPont launches AmberChrom SIL silica gel for peptide therapeutics purification
- ➤C8 and C18 chemistries target demanding peptide separations and final polishing
- ➤AmberChrom SIL integrates with existing resins across multiple purification stages
- ➤Application studies show competitive purity and yield with process stability
- ➤GLP-1 demand drives need for scalable, high-purity manufacturing workflows
Expert Statements
Hadi Fares, Bioprocessing Application Scientist for DuPont Water Solutions
“AmberChrom™ SIL silica gel provides customers with a high-performance reverse phase purification option that can be used independently or integrated with other chromatography technologies. Every peptide purification challenge is different. By expanding our portfolio with silica-based purification technology, we can help customers develop workflows that address their specific purity requirements and manufacturing goals while providing the technical support needed to scale with confidence.”
DuPont Launches AmberChrom™ SIL Silica Gel for Chromatography to Advance Manufacturing of GLP-1 and Other Peptide Therapeutics PR Newswire
New silica-based chromatography media helps biopharmaceutical manufacturers achieve demanding purity targets while supporting integrated purification workflows from crude purification through final polishing
Get started
Create a free account to read the full story.